Contribution of CsrR-Regulated Virulence Factors to the Progress and Outcome of Murine Skin Infections by Streptococcus pyogenes
暂无分享,去创建一个
[1] J. Musser,et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] T. Yutsudo,et al. Cysteine Protease Activity and Histamine Release from the Human Mast Cell Line HMC-1 Stimulated by Recombinant Streptococcal Pyrogenic Exotoxin B/Streptococcal Cysteine Protease , 2002, Infection and Immunity.
[3] V. Nizet,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[4] M. Wessels,et al. Group A Streptococcus tissue invasion by CD44-mediated cell signalling , 2001, Nature.
[5] M. Wessels,et al. Absence of a Cysteine Protease Effect on Bacterial Virulence in Two Murine Models of Human Invasive Group A Streptococcal Infection , 2001, Infection and Immunity.
[6] M. Boyle,et al. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. , 2001, The Journal of infectious diseases.
[7] V. DiRita,et al. Identification of a major, CsrRS-regulated secreted protein of Group A streptococcus. , 2001, Microbial pathogenesis.
[8] V. DiRita,et al. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. , 2001, The Journal of infectious diseases.
[9] J. Musser,et al. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. , 2001, The Journal of infectious diseases.
[10] A. Podbielski,et al. The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin‐binding and cysteine protease activity , 2001, Molecular microbiology.
[11] E. Hanski,et al. Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. , 2000, The Journal of infectious diseases.
[12] J. Musser,et al. Identification and Immunogenicity of Group AStreptococcus Culture Supernatant Proteins , 2000, Infection and Immunity.
[13] Malak Kotb,et al. Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases , 2000, Infection and Immunity.
[14] I. Stamenkovic,et al. CD44 as a receptor for colonization of the pharynx by group A Streptococcus. , 2000, The Journal of clinical investigation.
[15] D. Bessen,et al. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci , 2000, Molecular microbiology.
[16] V. Nizet,et al. Genetic Locus for Streptolysin S Production by Group A Streptococcus , 2000, Infection and Immunity.
[17] J. McNiff,et al. Humanized In Vivo Model for Streptococcal Impetigo , 2000, Infection and Immunity.
[18] V. DiRita,et al. A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenesVirulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B , 1999, Infection and Immunity.
[19] I. Ginsburg,et al. Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae? , 1999, FEMS immunology and medical microbiology.
[20] M. Federle,et al. A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus , 1999, Journal of bacteriology.
[21] M. Wessels,et al. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus , 1998, Molecular microbiology.
[22] P. Tsai,et al. Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection , 1998, Infection and Immunity.
[23] M. Wessels,et al. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. , 1998, The Journal of clinical investigation.
[24] D. Low,et al. Reduced Virulence of Group A Streptococcal Tn916 Mutants That Do Not Produce Streptolysin S , 1998, Infection and Immunity.
[25] J. Musser,et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.
[26] M. Wessels,et al. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.
[27] A. M. Marciel,et al. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease , 1996, Infection and immunity.
[28] L. Björck,et al. Streptococcal cysteine proteinase releases kinins: a virulence mechanism , 1996, The Journal of experimental medicine.
[29] J. Musser,et al. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. , 1994, The Journal of biological chemistry.
[30] J. Musser,et al. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.
[31] E. Maguin,et al. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature‐sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes , 1993, Molecular microbiology.
[32] D. Musher,et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). , 1993, The Journal of infectious diseases.
[33] Thomas J. White,et al. PCR protocols: a guide to methods and applications. , 1990 .
[34] R. Higuchi. 22 – RECOMBINANT PCR , 1990 .
[35] J. Alouf,et al. Production, purification, and assay of streptolysin S. , 1988, Methods in enzymology.
[36] R. Schwartz,et al. Immunologic abnormalities in HRS/J mice. I. Specific deficit in T lymphocyte helper function in a mutant mouse. , 1980, Journal of immunology.
[37] A. Reske-Kunz,et al. Disproportion in T-cell subpopulations in immunodeficient mutant hr/hr mice , 1979, The Journal of experimental medicine.